SCHEMBL4281340

SCHEMBL4281340

COc1ccc(Cc2ccc(CCO)cc2O)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 1/20 0.54
ALOX15 P16050 1/20 0.54
ESR1 P03372 1/20 0.50
CYP19A1 P11511 1/20 0.50
ESR2 Q92731 1/20 0.50
KDM4E B2RXH2 1/20 0.49
ALDH1A1 P00352 1/20 0.49
ALOX5 P09917 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
BACE1 P56817 1/20 0.49
AKR1B1 P15121 1/20 0.47
POLB P06746 1/20 0.44
CALM1 P0DP23 2/20 0.44
LTA4H P09960 1/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
SLC5A1 P13866 2/20 0.43
HSP90AA1 P07900 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4293661 0.87 ESR1 (0.49) IGF1RALOX15ESR1CYP19A1ESR2
SCHEMBL227700 0.85 ESR1 (0.61) IGF1RALOX15ESR1CYP19A1ESR2
SCHEMBL4003810 0.83 ESR1 (0.51) IGF1RALOX15ESR1CYP19A1ESR2
SCHEMBL4283809 0.82 MAPT (0.53) ALOX15KDM4EALDH1A1ALOX5GAA
SCHEMBL14283892 0.81 LTA4H (0.53) IGF1RALOX15ESR1CYP19A1ESR2
SCHEMBL2576302 0.81 ESR1 (0.49) IGF1RALOX15ESR1CYP19A1ESR2
SCHEMBL4283128 0.80 NPC1 (0.48) IGF1RALOX15ESR1CYP19A1ESR2
SCHEMBL28452332 0.79 LTA4H (0.61) IGF1RALOX15KDM4ECALM1LTA4H
SCHEMBL9006519 0.79 ESR1 (0.48) IGF1RALOX15ESR1CYP19A1ESR2
SCHEMBL4279793 0.79 CYP19A1 (0.48) IGF1RALOX15ESR1CYP19A1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101472937-A Benzylphenylglucopyranoside Derivatives DAIICHI SANKYO CO LTD (JP) 2009-07-01 CN disclosed
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 IGF1R 606/4885ALOX15 4342/4885ESR1 1331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.